Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Courtney Miller-Chism

General Oncology · BCM

View

Dr. Michele Evans

General Oncology · NIH

View

Dr. Hannah Knochelmann

General Oncology

View

Dr. Don Dizon

General Oncology · Tufts Medicine

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MMDr. Maria Moscvin

    Dr. Maria Moscvin

    Hematology & Oncology · General Oncology
    University of Chicago Medical Center
    maria

    Research

    Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.

    2025

    Via Blood

    Research

    Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis.

    2024

    Via Blood Advances

    Research

    Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.

    2023

    Via Blood Cancer Journal

    Research

    Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs.

    2023

    Via Clinical and Experimental Medicine

    Research

    Dissecting molecular mechanisms of immune microenvironment dysfunction in multiple myeloma and precursor conditions.

    2023

    Via Journal of Cancer Metastasis and Treatment

    Research

    Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.

    2022

    Via Blood Advances

    Research

    Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.

    2022

    Via Leukemia & Lymphoma

    Research

    Overcoming drug resistance by targeting protein homeostasis in multiple myeloma.

    2021

    Via Cancer Drug Resistance

    Research

    ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment.

    2021

    Via Blood Cancer Discovery

    Research

    Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

    2020

    Via Leukemia

    Research

    Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment.

    2020

    Via Frontiers in Oncology

    Research

    CD38 as an immunotherapeutic target in multiple myeloma.

    2018

    Via Expert Opinion on Biological Therapy

    Research

    Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor.

    2017

    Via Haematologica